RGEBX
Price
$71.86
Change
-$9.28 (-11.44%)
Updated
Dec 18 closing price
STCAX
Price
$15.47
Change
-$0.51 (-3.19%)
Updated
Dec 18 closing price
Ad is loading...

RGEBX vs STCAX

Header iconRGEBX vs STCAX Comparison
Open Charts RGEBX vs STCAXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$71.86
Change-$9.28 (-11.44%)
VolumeN/A
CapitalizationN/A
Virtus Silvant Large-Cap Growth Stk I
Price$15.47
Change-$0.51 (-3.19%)
VolumeN/A
CapitalizationN/A
RGEBX vs STCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. STCAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and STCAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 313B vs. STCAX (213M). RGEBX pays higher dividends than STCAX: RGEBX (0.16) vs STCAX (0.00). RGEBX was incepted earlier than STCAX: RGEBX (10 years) vs STCAX (32 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. STCAX (17.00). RGEBX has a lower initial minimum investment than STCAX: RGEBX (250) vs STCAX (100000). STCAX (35.13) and RGEBX (34.65) have marching annual gain over last year. STCAX return over 5 years is better than : 87.38 vs. RGEBX (52.56).
RGEBXSTCAXRGEBX / STCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years32 years-
Gain YTD33.32236.97790%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets313B213M146,948%
Annual Yield % from dividends0.160.00-
Returns for 1 year34.6535.1399%
Returns for 3 years16.9133.4451%
Returns for 5 years52.5687.3860%
Returns for 10 years89.8363.34142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INUV0.380.03
+8.42%
Inuvo
DOMO7.690.28
+3.78%
Domo
ELP6.090.16
+2.70%
Companhia Paranaense de Energia - COPEL
ANIP55.83-0.53
-0.94%
ANI Pharmaceuticals
COF181.18-3.93
-2.12%
Capital One Financial